Bright Minds Biosciences Announces Listing on Canadian Stock Exchange

Brightmindsbio10 Mar, 2022Health

Bright Minds Biosciences is a biosciences company focused on creating the next generation of psychedelic and related therapies for the treatment of mental health and central nervous system disorders, today announced that the Company’s common shares (the “Shares”) are expected to commence trading on the Canadian Securities Exchange. Bright Minds is focused on modern-day drug design and aims to improve on first-generation psychedelics by creating drugs that are selective serotonin agonists.